InvestorsHub Logo

dstock07734

05/27/23 6:01 PM

#596532 RE: exwannabe #596530

EX,

Has FDA approved the drug based on tumor agnostic rule based on the trial led by Dr. Subbiah?

This would give you a hint on what would happen to NWBO next.

Doc logic

05/27/23 7:50 PM

#596546 RE: exwannabe #596530

exwannabe,

Actually there is a diabetes drug that causes weight loss and helps control certain addictive behaviors. Guess what it is being used for even before trials. Try telling cancer patients with little to no hope that they can’t get DCVax-L with Poly ICLC once approved. Let regulators have fun with that!; ). This is real world too when breakthroughs show up. Best wishes.

space~farm

05/28/23 10:44 AM

#596610 RE: exwannabe #596530

Obviously there is competition in the oncology / immunotherapy space. I really can’t fathom some of these arguments lmao.

biosectinvestor

05/28/23 1:09 PM

#596634 RE: exwannabe #596530

There is plenty of room for other strategies, drugs and other technologies for addressing the complexity of the immune system. These other companies do not have the same technology or treatment and it’s very likely they work together best.

You really did not win that point. It was just a look over here and here argument, but it did not address the point.

dstock07734

05/28/23 1:36 PM

#596638 RE: exwannabe #596530

EX,

You gave credit to this company? Are you suggesting that this company is a better investment than NWBO? I bet true longs would laugh the minute they find who is active on Iovance board.


https://investorshub.advfn.com/Iovance-BiotherapeutIcs-IOVA-32529